Clinical trial
Phase 2 Study of TLK286 in Metastatic Breast Cancer
NCT00035841 is registered in ClinicalTrials.gov with Telik as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2 Study of TLK286 in Metastatic Breast Cancer
- Lead sponsor
- Telik
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- April 30, 2002
- Completion date
- July 31, 2004
- Enrollment
- 60
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.